Search research articles
Contact Us
Filters
Showing results (221-230 of 305) with videos related to
Page
of 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2013
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome
Patrick G Morris, Denise D Correa, Joachim Yahalom, et al.
Cancer
|
July 11, 2019
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872
Evanthia Galanis, S Keith Anderson, Erin L Twohy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
Phase II study of protracted daily temozolomide for low-grade gliomas in adults
Santosh Kesari, David Schiff, Jan Drappatz, et al.
Neuro-Oncology Advances
|
June 6, 2022
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)
Evanthia Galanis, S Keith Anderson, Erin Twohy, et al.
Neuro-Oncology
|
May 12, 2011
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab
Jeffrey S Wefel, Timothy Cloughesy, James L Zazzali, et al.
Neuro-Oncology
|
August 24, 2018
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group
Raymond Y Huang, Wenya Linda Bi, Michael Weller, et al.
Current Problems in Surgery
|
September 9, 2004
Brain metastases
Mark E Shaffrey, Melike Mut, Anthony L Asher, et al.
Neuro-Oncology
|
March 15, 2006
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study
Michael D Prados, Kathleen Lamborn, W K A Yung, et al.
Annals of Neurology
|
April 6, 2006
International study on low-grade primary central nervous system lymphoma
Kristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2007
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma
John G Kuhn, Susan M Chang, Patrick Y Wen, et al.
Page
of 31
Search research articles
Search
Showing results (221-230 of 305) with videos related to
Sort By:
Page
of 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2013
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome
Patrick G Morris, Denise D Correa, Joachim Yahalom, et al.
Cancer
|
July 11, 2019
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872
Evanthia Galanis, S Keith Anderson, Erin L Twohy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
Phase II study of protracted daily temozolomide for low-grade gliomas in adults
Santosh Kesari, David Schiff, Jan Drappatz, et al.
Neuro-Oncology Advances
|
June 6, 2022
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)
Evanthia Galanis, S Keith Anderson, Erin Twohy, et al.
Neuro-Oncology
|
May 12, 2011
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab
Jeffrey S Wefel, Timothy Cloughesy, James L Zazzali, et al.
Neuro-Oncology
|
August 24, 2018
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group
Raymond Y Huang, Wenya Linda Bi, Michael Weller, et al.
Current Problems in Surgery
|
September 9, 2004
Brain metastases
Mark E Shaffrey, Melike Mut, Anthony L Asher, et al.
Neuro-Oncology
|
March 15, 2006
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study
Michael D Prados, Kathleen Lamborn, W K A Yung, et al.
Annals of Neurology
|
April 6, 2006
International study on low-grade primary central nervous system lymphoma
Kristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2007
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma
John G Kuhn, Susan M Chang, Patrick Y Wen, et al.
Page
of 31